An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies
The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Zhu, J.-S. (2012) · Oncology Reports · doi:10.3892/or.2012.1623 · Cited by 38
RetractedHagiwara, S., Iwasaka, H., & Noguchi, T. (2007) · Journal of Anesthesia · doi:10.1007/s00540-006-0468-8 · Cited by 14
RetractedRelease of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221 · cited 4×
“However, HMGB1 has been proposed to contribute to the pathogenesis of various chronic inflammatory and autoimmune diseases (Scaffidi et al., 2002; Palumbo et al., 2004; Wang et al., 2004; Pisetsky et al., 2008; Voll et al., 2008; Andersson & Harris, 2010), and high serum levels of HMGB1 have been…”
BackgroundInfluentialHMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,385
Andersson, U., Wang, H., Palmblad, K., Aveberger, A.-C., Bloom, O., Erlandsson-Harris, H., Janson, A., Kokkola, R., Zhang, M., Yang, H., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.565 · Cited by 1,401
Understanding RAGE, the receptor for advanced glycation end products
Bierhaus, A., Humpert, P. M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., Stern, D. M., & Nawroth, P. P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0688-7 · Cited by 1,297 · cited 2×
“RAGE was originally identified as a receptor for advanced glycation end products (AGEs), but it also binds other structurally diverse ligands (Bierhaus et al., 2005), including not only HMGB1, but also S100 family members (Ostendorp et al.”
BackgroundThe multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
Schmidt, A. M., Yan, S. D., Yan, S. F., & Stern, D. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14002 · Cited by 1,253
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
Bonaldi, T. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg516 · Cited by 1,249
Reversing established sepsis with antagonists of endogenous high-mobility group box 1
Yang, H., Ochani, M., Li, J., Qiang, X., Tanovic, M., Harris, H. E., Susarla, S. M., Ulloa, L., Wang, H., DiRaimo, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2434651100 · Cited by 1,126
Endogenous HMGB1 regulates autophagy
Tang, D., Kang, R., Livesey, K. M., Cheh, C.-W., Farkas, A., Loughran, P., Hoppe, G., Bianchi, M. E., Tracey, K. J., Zeh, H. J., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200911078 · Cited by 951 · cited 2×
“…Andersson & Harris, 2010), atherosclerosis (Li et al., 2006), chronic kidney disease (Bruchfeld et al., 2008), systemic lupus erythematosus (SLE) (Jiang & Pisetsky, 2008; Li et al., 2010; Urbonaviciute & Voll, 2011), as well as in cancer pathogenesis (Ellerman at al., 2007; Tang et al., 2010b).”
BackgroundGardella, S., Andrei, C., Ferrera, D., Lotti, L. V., Torrisi, M. R., Bianchi, M. E., & Rubartelli, A. (2002) · EMBO reports · doi:10.1093/embo-reports/kvf198 · Cited by 926
Bustin, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5237 · Cited by 845
Brett, J., Schmidt, A. M., Yan, S. D., Zou, Y. S., Weidman, E., Pinsky, D. J., Nowygrod, R., Neeper, M. P., Przysiecki, C. T., & SHAW, A. R. (1993) · PubMed · Cited by 780
A New Group of Chromatin‐Associated Proteins with a High Content of Acidic and Basic Amino Acids
Goodwin, G. H., Sanders, C., & Johns, E. W. (1973) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1973.tb03026.x · Cited by 780
Schiraldi, M., Raucci, A., Muñoz, L. M., Livoti, E., Celona, B., Venereau, E., Apuzzo, T., De Marchis, F., Pedotti, M., Bachi, A., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111739 · Cited by 676
Huttunen, H. J., Fages, C., & Rauvala, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19919 · Cited by 628
Riedemann, N. C., Guo, R., & Ward, P. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19523 · Cited by 624
Abraham, E. (1998) · The Lancet · doi:10.1016/s0140-6736(00)80009-4 · Cited by 624
Abraham, E. H., Anzueto, A., Gutiérrez, G., Tessler, S., Pedro, G. S. S., Wunderink, R. G., Nogare, A. R. D., Nasraway, S. A., Berman, S., Cooney, R. N., et al. (1998) · PubMed · Cited by 622
Sparvero, L. J., Asafu-Adjei, D., Kang, R., Tang, D., Amin, N., Im, J., Rutledge, R., Lin, B., Amoscato, A. A., Zeh, H. J., et al. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-17 · Cited by 622
Glycyrrhizin Binds to High-Mobility Group Box 1 Protein and Inhibits Its Cytokine Activities
Mollica, L., De Marchis, F., Spitaleri, A., Dallacosta, C., Pennacchini, D., Zamai, M., Agresti, A., Trisciuoglio, L., Musco, G., & Bianchi, M. E. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.03.007 · Cited by 612
Specific Recognition of Cruciform DNA by Nuclear Protein HMG1
Bianchi, M. E., Beltrame, M., & Paonessa, G. (1989) · Science · doi:10.1126/science.2922595 · Cited by 601
Kim, J.-B., Sig Choi, J., Yu, Y.-M., Nam, K., Piao, C.-S., Kim, S.-W., Lee, M.-H., Han, P.-L., Park, J.-S., & Lee, J.-K. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3815-05.2006 · Cited by 579
Yang, H., Antoine, D. J., Andersson, U., & Tracey, K. J. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1212662 · Cited by 542
Li, J., & Schmidt, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16498 · Cited by 525
Liliensiek, B., Weigand, M. A., Bierhaus, A., Nicklas, W., Kasper, M., Hofer, S., Plachky, J., Gröne, H.-J., Kurschus, F. C., Schmidt, A. M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18704 · Cited by 524
High-mobility group box 1 and cancer
Tang, D., Kang, R., Zeh III, H. J., & Lotze, M. T. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.11.014 · Cited by 512
Dumitriu, I. E., Baruah, P., Valentinis, B., Voll, R. E., Herrmann, M., Nawroth, P. P., Arnold, B., Bianchi, M. E., Manfredi, A. A., & Rovere-Querini, P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7506 · Cited by 503
RAGE is the Major Receptor for the Proinflammatory Activity of HMGB1 in Rodent Macrophages
Kokkola, R., Andersson, Å., Mullins, G., Östberg, T., Treutiger, C. ‐., Arnold, B., Nawroth, P., Andersson, U., Harris, R. A., & Harris, H. E. (2005) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2005.01534.x · Cited by 496
Specific Binding of Chromosomal Protein HMG1 to DNA Damaged by the Anticancer Drug Cisplatin
Pil, P. M., & Lippard, S. J. (1992) · Science · doi:10.1126/science.1566071 · Cited by 496
Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation
Palumbo, R., Sampaolesi, M., De Marchis, F., Tonlorenzi, R., Colombetti, S., Mondino, A., Cossu, G., & Bianchi, M. E. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200304135 · Cited by 469
Structural features of the HMG chromosomal proteins and their genes
Bustin, M., A. Lehn, D., & Landsman, D. (1990) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(90)90092-g · Cited by 469
Degryse, B., Bonaldi, T., Scaffidi, P., Müller, S., Resnati, M., Sanvito, F., Arrigoni, G., & Bianchi, M. E. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.6.1197 · Cited by 451
Extracellular role of HMGB1 in inflammation and sepsis
Wang, H., Yang, H., & Tracey, K. J. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2003.01302.x · Cited by 439
Sundén-Cullberg, J., Norrby-Teglund, A., Rouhiainen, A., Rauvala, H., Herman, G., Tracey, K. J., Lee, M. L., Andersson, J., Tokics, L., & Treutiger, C. J. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000155991.88802.4d · Cited by 428
Muller, S. (2001) · The EMBO Journal · doi:10.1093/emboj/20.16.4337 · Cited by 426
Structure of the HMG box motif in the B-domain of HMG1.
Weir, H. M., Kraulis, P. J., Hill, C. S., Raine, A. R., Laue, E. D., & Thomas, J. O. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05776.x · Cited by 403
Structural Basis for the Proinflammatory Cytokine Activity of High Mobility Group Box 1
Li, J., Kokkola, R., Tabibzadeh, S., Yang, R., Ochani, M., Qiang, X., Harris, H. E., Czura, C. J., Wang, H., Ulloa, L., et al. (2003) · Molecular Medicine · doi:10.1007/bf03402105 · Cited by 368
Youn, J. H., & Shin, J.-S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7889 · Cited by 366
Masquerader: High Mobility Group Box-1 and Cancer
Ellerman, J. E., Brown, C. K., de Vera, M., Zeh, H. J., Billiar, T., Rubartelli, A., & Lotze, M. T. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1953 · Cited by 355
Semino, C., Angelini, G., Poggi, A., & Rubartelli, A. (2005) · Blood · doi:10.1182/blood-2004-10-3906 · Cited by 328
Kokkola, R., Li, J., Sundberg, E., Aveberger, A. ‐., Palmblad, K., Yang, H., Tracey, K. J., Andersson, U., & Harris, H. E. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11161 · Cited by 325
Paull, T. T., Haykinson, M. J., & Johnson, R. C. (1993) · Genes & Development · doi:10.1101/gad.7.8.1521 · Cited by 323
Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1
Tang, D., Shi, Y., Kang, R., Li, T., Xiao, W., Wang, H., & Xiao, X. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0806540 · Cited by 312
HMGB1 as a DNA-binding cytokine
Andersson, U., Erlandsson-Harris, H., Yang, H., & Tracey, K. J. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.6.1084 · Cited by 302
Solution structure of a DNA-binding domain from HMG1
Read, C. M., Cary, P. D., Crane-Robinson, C., Driscoll, P. C., & Norman, D. G. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.15.3427 · Cited by 272
HMG1 and 2: architectural DNA-binding proteins
Thomas, J. O. (2001) · Biochemical Society Transactions · doi:10.1042/bst0290395 · Cited by 254
The DNA chaperone HMGB1 facilitates ACF/CHRAC-dependent nucleosome sliding
Bonaldi, T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf692 · Cited by 254
Palumbo, R., Galvez, B. G., Pusterla, T., De Marchis, F., Cossu, G., Marcu, K. B., & Bianchi, M. E. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200704015 · Cited by 250
Structural Basis for Ligand Recognition and Activation of RAGE
Koch, M., Chitayat, S., Dattilo, B. M., Schiefner, A., Diez, J., Chazin, W. J., & Fritz, G. (2010) · Structure · doi:10.1016/j.str.2010.05.017 · Cited by 244
Ito, I., Fukazawa, J., & Yoshida, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608467200 · Cited by 242
Structural and functional insights into RAGE activation by multimeric S100B
Ostendorp, T., Leclerc, E., Galichet, A., Koch, M., Demling, N., Weigle, B., Heizmann, C. W., Kroneck, P. M., & Fritz, G. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601805 · Cited by 241
Kim, S.-W., Jin, Y., Shin, J.-H., Kim, I.-D., Lee, H.-K., Park, S., Han, P.-L., & Lee, J.-K. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.056 · Cited by 239
Tumor necrosis factor in the pathogenesis of infectious diseases
BEUTLER, B., & GRAU, G. E. (1993) · Critical Care Medicine · doi:10.1097/00003246-199310001-00003 · Cited by 235
Yang, R., Harada, T., Mollen, K. P., Prince, J. M., Levy, R. M., Englert, J. A., Gallowitsch-Puerta, M., Yang, L., Yang, H., Tracey, K. J., et al. (2006) · Molecular Medicine · doi:10.2119/2006-00010.yang · Cited by 224
HMGB1 and leukocyte migration during trauma and sterile inflammation
Venereau, E., Schiraldi, M., Uguccioni, M., & Bianchi, M. E. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2012.10.037 · Cited by 211
Angus, D. C., Yang, L., Kong, L., Kellum, J. A., Delude, R. L., Tracey, K. J., & Weissfeld, L. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000259534.68873.2a · Cited by 210
RAGE and RAGE ligands in cancer
Logsdon, C., Fuentes, M., Huang, E., & Arumugam, T. (2007) · Current Molecular Medicine · doi:10.2174/156652407783220697 · Cited by 209 · cited 2×
“…HMGB1 has been implicated in mediating several pathological conditions including sepsis (Kokkola et al., 2005; Liliensiek et al., 2004; Yang et al., 2004; Lutterloh et al., 2007) aswell as cancer (Logsdon et al., 2007; Sparvero et al., 2009), diabetes, and Alzheimer's disease (Han et al., 2011).”
BackgroundThe DNA-bending protein HMG-1 enhances progesterone receptor binding to its target DNA sequences.
Oñate, S. A., Prendergast, P., Wagner, J. P., Nissen, M., Reeves, R., Pettijohn, D. E., & Edwards, D. P. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.5.3376 · Cited by 209
Reduced fertility and spermatogenesis defects in mice lacking chromosomal protein Hmgb2
Ronfani, L., Ferraguti, M., Croci, L., Ovitt, C. E., Schöler, H. R., Consalez, G. G., & Bianchi, M. E. (2001) · Development · doi:10.1242/dev.128.8.1265 · Cited by 199
Dattilo, B. M., Fritz, G., Leclerc, E., Vander Kooi, C. W., Heizmann, C. W., & Chazin, W. J. (2007) · Biochemistry · doi:10.1021/bi7003735 · Cited by 192
Goldstein, R. S., Bruchfeld, A., Yang, L., Qureshi, A. R., Gallowitsch-Puerta, M., Patel, N. B., Huston, B. J., Chavan, S., Rosas-Ballina, M., Gregersen, P. K., et al. (2007) · Molecular Medicine · doi:10.2119/2006-00108.goldstein · Cited by 187
Pisetsky, D. S., Erlandsson-Harris, H., & Andersson, U. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2440 · Cited by 187
Bianchi, M. E., & Beltrame, M. (2000) · EMBO Reports · doi:10.1093/embo-reports/kvd030 · Cited by 174
HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation
Nogueira-Machado, J. A., Volpe, C. M. D. O., Veloso, C. A., & Chaves, M. M. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.575360 · Cited by 170
Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis
Davé, S. H., Tilstra, J. S., Matsuoka, K., Li, F., DeMarco, R. A., Beer-Stolz, D., Sepulveda, A. R., Fink, M. P., Lotze, M. T., & Plevy, S. E. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1008662 · Cited by 170
Hardman, C. H., Broadhurst, R. W., Raine, A. R. C., Grasser, K. D., Thomas, J. O., & Laue, E. D. (1995) · Biochemistry · doi:10.1021/bi00051a007 · Cited by 168
Lutterloh, E. C., Opal, S. M., Pittman, D. D., Keith, J. C., Tan, X.-Y., Clancy, B. M., Palmer, H., Milarski, K., Sun, Y., Palardy, J. E., et al. (2007) · Critical Care · doi:10.1186/cc6184 · Cited by 168
S100P-Derived RAGE Antagonistic Peptide Reduces Tumor Growth and Metastasis
Arumugam, T., Ramachandran, V., Gomez, S. B., Schmidt, A. M., & Logsdon, C. D. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0221 · Cited by 167 · cited 2×
“Importantly, systemic in vivo administration of the peptide inhibited glioma tumor growth and also reduced the growth and metastasis of pancreatic tumors (Arumugam et al., 2012). ibitors as potential therapeutic agents in HMGB1-related pathologies, era.2013.11.001”
BackgroundInfluentialHMGB1: The Central Cytokine for All Lymphoid Cells
Li, G., Liang, X., & Lotze, M. T. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00068 · Cited by 166
Park, H., & Boyington, J. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.169276 · Cited by 152
A Major Ingredient of Green Tea Rescues Mice from Lethal Sepsis Partly by Inhibiting HMGB1
Li, W., Ashok, M., Li, J., Yang, H., Sama, A. E., & Wang, H. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001153 · Cited by 143
Li, W., Li, J., Ashok, M., Wu, R., Chen, D., Yang, L., Yang, H., Tracey, K. J., Wang, P., Sama, A. E., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3856 · Cited by 138
HMGB1 inhibitor glycyrrhizin attenuates intracerebral hemorrhage-induced injury in rats
Ohnishi, M., Katsuki, H., Fukutomi, C., Takahashi, M., Motomura, M., Fukunaga, M., Matsuoka, Y., Isohama, Y., Izumi, Y., Kume, T., et al. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.06.026 · Cited by 137
The role of HMGB1 in the pathogenesis of rheumatic disease
Andersson, U., & Harris, H. E. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.11.003 · Cited by 137
Role of HMGB1 in cardiovascular diseases
Li, W., Sama, A., & Wang, H. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.10.010 · Cited by 127
MOSEVITSKY, M. I., NOVITSKAYA, V. A., IOGANNSEN, M. G., & ZABEZHINSKY, M. A. (1989) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1989.tb15116.x · Cited by 127
Quercetin Prevents LPS-Induced High-Mobility Group Box 1 Release and Proinflammatory Function
Tang, D., Kang, R., Xiao, W., Zhang, H., Lotze, M. T., Wang, H., & Xiao, X. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0119oc · Cited by 123
Schierbeck, H., Lundbäck, P., Palmblad, K., Klevenvall, L., Erlandsson-Harris, H., Andersson, U., & Ottosson, L. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00264 · Cited by 122
Zhai, C., Zhang, M.-Q., Zhang, Y., Xu, H., Wang, J., An, G., Wang, Y., & Li, L. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.112 · Cited by 117
Tumor immunity times out: TIM-3 and HMGB1
Tang, D., & Lotze, M. T. (2012) · Nature Immunology · doi:10.1038/ni.2396 · Cited by 116
Wang, L., Zhang, X., Liu, L., Yang, R., Cui, L., & Li, M. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.01.030 · Cited by 116
The primary structures of non‐histone chromosomal proteins HMG 1 and 2
Walker, J. M., Gooderham, K., Hastings, J. R. B., Mayes, E. L. V., & Johns, E. W. (1980) · FEBS Letters · doi:10.1016/0014-5793(80)80453-4 · Cited by 110
RAGE: The Beneficial and Deleterious Effects by Diverse Mechanisms of Actions
Han, S.-H., Kim, Y. H., & Mook-Jung, I. (2011) · Molecules and Cells · doi:10.1007/s10059-011-0030-x · Cited by 108
Ogiku, M., Kono, H., Hara, M., Tsuchiya, M., & Fujii, H. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.182592 · Cited by 107
Musumeci, D., & Montesarchio, D. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.07.011 · Cited by 103
Self-citationGong, G., Yuan, L.-B., Hu, L., Wu, W., Yin, L., Hou, J.-L., Liu, Y.-H., & Zhou, L.-S. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.151 · Cited by 100
Goodwin, G. H., & Johns, E. W. (1977) · Methods in cell biology · doi:10.1016/s0091-679x(08)60104-1 · Cited by 100
Nagato, M., Okamoto, K., Abe, Y., Higure, A., & Yamaguchi, K. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a55184 · Cited by 98
High Mobility Group Box Protein-1 Correlates with Renal Function in Chronic Kidney Disease (CKD)
Bruchfeld, A., Qureshi, A. R., Lindholm, B., Barany, P., Yang, L., Stenvinkel, P., & Tracey, K. J. (2008) · Molecular Medicine · doi:10.2119/2007-00107.bruchfeld · Cited by 96
Preferential Binding of High Mobility Group 1 Protein to UV-damaged DNA
Pasheva, E. A., Pashev, I. G., & Favre, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.38.24730 · Cited by 90
Urbonaviciute, V., & Voll, R. E. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02432.x · Cited by 89
The Role of Glycyrrhizin, an Inhibitor of HMGB1 Protein, in Anticancer Therapy
Smolarczyk, R., Cichoń, T., Matuszczak, S., Mitrus, I., Lesiak, M., Kobusińska, M., Kamysz, W., Jarosz–Biej, M., Sieroń, A. L., & Szala, S. (2012) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0183-0 · Cited by 83
Li, J., Qu, X., & Schmidt, A. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.30870 · Cited by 82
Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis
Zickert, A., Palmblad, K., Sundelin, B., Chavan, S. S., Tracey, K. J., Bruchfeld, A. N., & Gunnarsson, I. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3747 · Cited by 80
LI, J., XIE, H., WEN, T., LIU, H., ZHU, W., & CHEN, X. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.090663 · Cited by 78
Li, W., Li, J., Sama, A. E., & Wang, H. (2013) · Molecular Medicine · doi:10.2119/molmed.2013.00064 · Cited by 75
Chorny, A., & Delgado, M. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070969 · Cited by 72
Lee, W., Ku, S., Bae, J. W., & Bae, J.-S. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.03.003 · Cited by 71
Liu, M., Yu, Y., Jiang, H., Zhang, L., Zhang, P.-P., Yu, P., Jia, J.-G., Chen, R.-Z., Zou, Y.-Z., & Ge, J.-B. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.8 · Cited by 69 · cited 1×
“On the other hand, administration of simvastatin in ApoE(−/−) mice markedly attenuated the vascular inflammation and atherosclerotic lesion area, and decreased the aortic expression of HMGB1, RAGE, VCAM-1, and MCP-1, which are elevated in this kind of diseases (Liu et al., 2013).”
BackgroundThe HMGB1 acidic tail regulates HMGB1 DNA binding specificity by a unique mechanism
Wang, Q., Zeng, M., Wang, W., & Tang, J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.130 · Cited by 67
Jiang, W., & Pisetsky, D. S. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.074484 · Cited by 66
Gong, Q., Xu, J. ‐., Yin, H., Liu, S. ‐., Duan, L. ‐., & Bian, Z. ‐. (2009) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2008.02194.x · Cited by 66
Hagiwara, S., Iwasaka, H., Togo, K., & Noguchi, T. (2008) · Inflammation · doi:10.1007/s10753-008-9069-z · Cited by 57
Dipotassium Glycyrrhizate Inhibits HMGB1-Dependent Inflammation and Ameliorates Colitis in Mice
Vitali, R., Palone, F., Cucchiara, S., Negroni, A., Cavone, L., Costanzo, M., Aloi, M., Dilillo, A., & Stronati, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066527 · Cited by 57
Takata, K., Takada, T., Ito, A., Asai, M., Tawa, M., Saito, Y., Ashihara, E., Tomimoto, H., Kitamura, Y., & Shimohama, S. (2012) · International Journal of Alzheimer's Disease · doi:10.1155/2012/685739 · Cited by 57
Src family kinases are necessary for cell migration induced by extracellular HMGB1
Palumbo, R., De Marchis, F., Pusterla, T., Conti, A., Alessio, M., & Bianchi, M. E. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0908581 · Cited by 57
The Anti-Inflammatory Activity of HMGB1 A Box Is Enhanced When Fused with C-Terminal Acidic Tail
Gong, W., Zheng, Y., Fan, C., Li, Y., Xu, Z., Huang, G., Gao, X., Li, S., & He, F. (2010) · BioMed Research International · doi:10.1155/2010/915234 · Cited by 54
HMGB1 protein inhibits DNA replication in vitro: A role of the acetylation and the acidic tail
Topalova, D., Ugrinova, I., Pashev, I. G., & Pasheva, E. A. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.11.014 · Cited by 53
Gwak, G. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i7.679 · Cited by 52
Todorova, J., & Pasheva, E. A. (2011) · Oncology Letters · doi:10.3892/ol.2011.459 · Cited by 52
Tanshinone IIA sodium sulfonate facilitates endocytic HMGB1 uptake
Zhang, Y., Li, W., Zhu, S., Jundoria, A., Li, J., Yang, H., Fan, S., Wang, P., Tracey, K. J., Sama, A. E., et al. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.09.015 · Cited by 51
Wang, W., Zhao, F., Fang, Y., Li, X., Shen, L., Cao, T.-W., & Zhu, H. (2013) · Critical Care · doi:10.1186/cc12558 · Cited by 49
Solution Structure of the Soluble Receptor for Advanced Glycation End Products (sRAGE)
Sárkány, Z., Ikonen, T. P., Ferreira‐da‐Silva, F., Saraiva, M. J., Svergun, D. I., & Damas, A. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.223438 · Cited by 49
Kuroiwa, Y., Takakusagi, Y., Kusayanagi, T., Kuramochi, K., Imai, T., Hirayama, T., Ito, I., Yoshida, M., Sakaguchi, K., & Sugawara, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063073 · Cited by 46
Ugrinova, I., Pashev, I. G., & Pasheva, E. A. (2009) · Biochemistry · doi:10.1021/bi9004304 · Cited by 46
Yotov, W. V., & St-Arnaud, R. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.13.3516 · Cited by 44
Hagiwara, S., Iwasaka, H., Matsumoto, S., Hasegawa, A., Yasuda, N., & Noguchi, T. (2010) · Shock · doi:10.1097/shk.0b013e3181b0ef7b · Cited by 42
Native HMGB1 protein inhibits repair of cisplatin-damaged nucleosomes in vitro
Ugrinova, I., Zlateva, S., Pashev, I. G., & Pasheva, E. A. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.01.010 · Cited by 41
Musumeci, D., Oliviero, G., Roviello, G. N., Bucci, E. M., & Piccialli, G. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200305t · Cited by 40
Self-citationDu, D., Yan, J., Ren, J., Lv, H., Li, Y., Xu, S., Wang, Y., Ma, S., Qu, J., Tang, W., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301248y · Cited by 38
Tang, Y., Lv, B., Wang, H., Xiao, X., & Zuo, X. (2008) · International Immunopharmacology · doi:10.1016/j.intimp.2008.07.014 · Cited by 33
Gabexate Mesilate Inhibits the Expression of HMGB1 in Lipopolysaccharide-Induced Acute Lung Injury
Hidaka, S., Iwasaka, H., Hagiwara, S., & Noguchi, T. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2009.05.039 · Cited by 33
Musumeci, D., Bucci, E. M., Roviello, G. N., Sapio, R., Valente, M., Moccia, M., Bianchi, M. E., & Pedone, C. (2011) · Molecular BioSystems · doi:10.1039/c1mb05009e · Cited by 25
Self-citationNatural killer cells, dendritic cells, and the alarmin high-mobility group box 1 protein
Gougeon, M., & Bras, M. (2011) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328349b089 · Cited by 24
The role of high-mobility group box 1 protein in the pathogenesis of autoimmune diseases
Voll, R. E., Urbonaviciute, V., Fürnrohr, B. G., i, M. H., & Kalden, J. R. (2008) · Current Rheumatology Reports · doi:10.1007/s11926-008-0054-1 · Cited by 13
Novel pathways and therapies in experimental diabetic atherosclerosis
Koulis, C., de Haan, J. B., & Allen, T. J. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.13 · Cited by 10
NMR characterization of the C-terminal tail of full-length RAGE in a membrane mimicking environment
Borsi, V., Cerofolini, L., Fragai, M., & Luchinat, C. (2012) · Journal of Biomolecular NMR · doi:10.1007/s10858-012-9671-0 · Cited by 9
Hairpin ODN-based ligands as potential inhibitors of HMGB1 cytokine activity
Musumeci, D., Roviello, G. N., Montesarchio, D., Sapio, R., Valente, M., Anrò, V., & Bucci, E. M. (2013) · RSC Advances · doi:10.1039/c3ra41915k · Cited by 7
Self-citation
Cited by
Kang, R., Chen, R., Zhang, Q., Hou, W., Wu, S., Cao, L., Huang, J., Yu, Y., Fan, X.-G., Yan, Z., et al. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.05.001 · Cited by 956
Denning, N.-L., Aziz, M., Gurien, S. D., & Wang, P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02536 · Cited by 623
The Role of HMGB1 in the Pathogenesis of Inflammatory and Autoimmune Diseases
Magna, M., & Pisetsky, D. S. (2014) · Molecular Medicine · doi:10.2119/molmed.2013.00164 · Cited by 358
Paudel, Y. N., Shaikh, M. F., Chakraborti, A., Kumari, Y., Aledo-Serrano, Á., Aleksovska, K., Alvim, M. K. M., & Othman, I. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00628 · Cited by 311
Bailly, C., & Vergoten, G. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107618 · Cited by 301
Metadata
- Authors
- Musumeci, D., Roviello, G. N., & Montesarchio, D.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2014-03
- Volume
- 141
- Issue
- 3
- Pages
- 347-357
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W1977347871
- Cited by
- 334
- References
- 129
- FWCI
- 12.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.